Why the study?
Does oral methyldopa reduce plasma renin activity in human volunteers?
Does oral methyldopa reduce plasma renin activity in human volunteers?
Methyldopa simultaneously decreases mean arterial pressure and plasma renin activity, suggesting a potential causal relationship between these physiological effects.
Answers are grounded in this paper and cite their sources.
Supports methyldopa's renin-lowering effect beyond BP reduction; hypothesis-generating and should not change practice.
The effect of methyldopa on plasma renin activity was studied in one hypertensive and four normotensive human volunteers. Peripheral venous blood for the estimation of plasma renin activity was obtained with the subjects supine and in a 70° head-up tilted position before, during and, in two subjects, after treatment with oral methyldopa. Despite a reduction in mean arterial pressure, the plasma renin activity was decreased by methyldopa in each subject. The increase in plasma renin activity associated with tilting, however, was not significantly suppressed by methyldopa. These results indicate that treatment with methyldopa can simultaneously decrease mean arterial pressure and plasma renin activity and it is possible that these effects may be causally related.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: